Multimode Ultrasound Model for Predicting the Early Treatment Response of Anti-VEGF Agents Plus Anti-PD-1 Antibody in Patients with Unresectable Hepatocellular Carcinoma.
Zi-Nan LiangHong WangWen-Chao CuiWei ZhouSong WangZhong-Yi ZhangWei WuKun YanYong-Li JiWei YangPublished in: Ultrasound in medicine & biology (2024)
Nomograms based on US, CDFI, CEUS and clinical characteristics could help to non-invasively predict the response to treatment with anti-PD-1 antibodies plus anti-VEGF agents.